CORC

浏览/检索结果: 共63条,第1-10条 帮助

已选(0)清除 条数/页:   排序方式:
Gefitinib enhances the anti-tumor immune response against EGFR-mutated NSCLC by upregulating B7H5 expression and activating T cells via CD28H 期刊论文
INTERNATIONAL JOURNAL OF ONCOLOGY, 2022, 卷号: 61
作者:  Guo, Huihui;  Zhang, Xilin;  Xie, Shangzhi;  Chen, Tianwei;  Xie, Dong
收藏  |  浏览/下载:17/0  |  提交时间:2022/12/22
Impact of clinical and molecular features on efficacy and outcome of patients with non-small cell lung cancer receiving second-line osimertinib 期刊论文
BMC CANCER, 2022, 卷号: 22
作者:  Jin, Ying;  Lin, Chen;  Shi, Xun;  He, Qiong;  Yan, Junrong
收藏  |  浏览/下载:17/0  |  提交时间:2022/12/23
Efficacy and safety of anlotinib with and without EGFR-TKIs or immunotherapy in the treatment of elder patients with non-small-cell lung cancer: a retrospective study 期刊论文
BMC PULMONARY MEDICINE, 2022, 卷号: 22
作者:  Wang, Wenxian;  Shao, Lan;  Xu, Yibing;  Song, Zhengbo;  Lou, Guangyuan
收藏  |  浏览/下载:12/0  |  提交时间:2022/12/23
The Role of Anti-EGFR Monoclonal Antibody in mCRC Maintenance Therapy 期刊论文
FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 卷号: 9
作者:  Yuan, Meiqin;  Wang, Zeng;  Lv, Wangxia;  Pan, Hongming
收藏  |  浏览/下载:18/0  |  提交时间:2022/05/16
LS-106, a novel EGFR inhibitor targeting C797S, exhibits antitumor activities both in vitro and in vivo 期刊论文
CANCER SCIENCE, 2021, 页码: 12
作者:  Liu, Yingqiang;  Lai, Mengzhen;  Li, Shan;  Wang, Yanan;  Feng, Fang
收藏  |  浏览/下载:60/0  |  提交时间:2022/01/18
Tumor Mutation Burden Correlates With Efficacy of Chemotherapy/Targeted Therapy in Advanced Non-Small Cell Lung Cancer 期刊论文
FRONTIERS IN ONCOLOGY, 2020, 卷号: 10
作者:  Lin, Chen;  Shi, Xun;  Zhao, Jun;  He, Qiong;  Fan, Yun
收藏  |  浏览/下载:21/0  |  提交时间:2020/10/26
Design and synthesis of selective degraders of EGFR(L858R/T790M) mutant 期刊论文
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 卷号: 192, 页码: 14
作者:  Zhang, Xin;  Xu, Fang;  Tong, Linjiang;  Zhang, Tao;  Xie, Hua
收藏  |  浏览/下载:79/0  |  提交时间:2020/07/01
Structure-Based Design of 5-Methylpyrimidopyridone Derivatives as New Wild-Type Sparing Inhibitors of the Epidermal Growth Factor Receptor Triple Mutant (EGFR(L858R/T790M/C797S)) 期刊论文
JOURNAL OF MEDICINAL CHEMISTRY, 2019, 卷号: 62, 期号: 15, 页码: 7302-7308
作者:  Shen, Jiayi;  Zhang, Tao;  Zhu, Su-Jie;  Sun, Min;  Tong, Linjiang
收藏  |  浏览/下载:30/0  |  提交时间:2020/07/01
CMAB009 plus irinotecan versus irinotecan-only as second-line treatment after fluoropyrimidine and oxaliplatin failure in KRAS wild-type metastatic colorectal cancer patients: promising findings from a prospective, open-label, randomized, phase III trial 期刊论文
CANCER COMMUNICATIONS, 2019, 卷号: 39
作者:  Shi, Yuankai;  Li, Jin;  Xu, Jianming;  Sun, Yan;  Wang, Liwei
收藏  |  浏览/下载:112/0  |  提交时间:2019/12/05
Predicting EGFR mutation status in lung adenocarcinoma on computed tomography image using deep learning 期刊论文
EUROPEAN RESPIRATORY JOURNAL, 2019, 卷号: 53, 期号: 3, 页码: 11
作者:  Wang, Shuo;  Shi, Jingyun;  Ye, Zhaoxiang;  Dong, Di;  Yu, Dongdong
收藏  |  浏览/下载:94/0  |  提交时间:2019/04/30


©版权所有 ©2017 CSpace - Powered by CSpace